These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 26310359)
1. Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-α-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers. Liang DS; Su HT; Liu YJ; Wang AT; Qi XR Biomaterials; 2015 Dec; 71():11-23. PubMed ID: 26310359 [TBL] [Abstract][Full Text] [Related]
2. Enhance Cancer Cell Recognition and Overcome Drug Resistance Using Hyaluronic Acid and α-Tocopheryl Succinate Based Multifunctional Nanoparticles. Liang D; Wang AT; Yang ZZ; Liu YJ; Qi XR Mol Pharm; 2015 Jun; 12(6):2189-202. PubMed ID: 25945733 [TBL] [Abstract][Full Text] [Related]
3. tLyP-1 Peptide Functionalized Human H Chain Ferritin for Targeted Delivery of Paclitaxel. Ma Y; Li R; Dong Y; You C; Huang S; Li X; Wang F; Zhang Y Int J Nanomedicine; 2021; 16():789-802. PubMed ID: 33568906 [TBL] [Abstract][Full Text] [Related]
4. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer. Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758 [TBL] [Abstract][Full Text] [Related]
5. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration. Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300 [TBL] [Abstract][Full Text] [Related]
6. Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and α-tocopheryl succinate enhance anti-tumor effect in vivo. Lei X; Li K; Liu Y; Wang ZY; Ruan BJ; Wang L; Xiang A; Wu D; Lu Z Int J Nanomedicine; 2017; 12():5701-5715. PubMed ID: 28848348 [TBL] [Abstract][Full Text] [Related]
7. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation. Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802 [TBL] [Abstract][Full Text] [Related]
8. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth. Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853 [TBL] [Abstract][Full Text] [Related]
9. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery. Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433 [TBL] [Abstract][Full Text] [Related]
10. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells. Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859 [TBL] [Abstract][Full Text] [Related]
11. An injectable acellular matrix scaffold with absorbable permeable nanoparticles improves the therapeutic effects of docetaxel on glioblastoma. Xu HL; Mao KL; Lu CT; Fan ZL; Yang JJ; Xu J; Chen PP; ZhuGe DL; Shen BX; Jin BH; Xiao J; Zhao YZ Biomaterials; 2016 Nov; 107():44-60. PubMed ID: 27614158 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304 [TBL] [Abstract][Full Text] [Related]
13. Mussel-Inspired Hyaluronic Acid Derivative Nanostructures for Improved Tumor Targeting and Penetration. Lee SY; Park JH; Ko SH; Shim JS; Kim DD; Cho HJ ACS Appl Mater Interfaces; 2017 Jul; 9(27):22308-22320. PubMed ID: 28621523 [TBL] [Abstract][Full Text] [Related]
14. Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles. Yang Y; Long Y; Wang Y; Ren K; Li M; Zhang Z; Xiang B; He Q Int J Pharm; 2020 Mar; 577():119085. PubMed ID: 32001290 [TBL] [Abstract][Full Text] [Related]
15. F3 peptide-functionalized PEG-PLA nanoparticles co-administrated with tLyp-1 peptide for anti-glioma drug delivery. Hu Q; Gu G; Liu Z; Jiang M; Kang T; Miao D; Tu Y; Pang Z; Song Q; Yao L; Xia H; Chen H; Jiang X; Gao X; Chen J Biomaterials; 2013 Jan; 34(4):1135-45. PubMed ID: 23146434 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin. Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864 [TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases-2/9-sensitive peptide-conjugated polymer micelles for site-specific release of drugs and enhancing tumor accumulation: preparation and in vitro and in vivo evaluation. Zhang X; Wang X; Zhong W; Ren X; Sha X; Fang X Int J Nanomedicine; 2016; 11():1643-61. PubMed ID: 27217744 [TBL] [Abstract][Full Text] [Related]
18. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy. Gao H; Zhang Q; Yang Y; Jiang X; He Q Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586 [TBL] [Abstract][Full Text] [Related]
19. Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel. Hu Q; Gao X; Gu G; Kang T; Tu Y; Liu Z; Song Q; Yao L; Pang Z; Jiang X; Chen H; Chen J Biomaterials; 2013 Jul; 34(22):5640-50. PubMed ID: 23639530 [TBL] [Abstract][Full Text] [Related]
20. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel. Wang X; Cheng R; Zhong Z Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]